Intensity of cervical inflammatory reaction as a risk factor for recurrence of carcinoma of the uterine cervix in stages IB and IIA
- PMID: 17992395
- PMCID: PMC11020539
- DOI: 10.1590/s1516-31802007000400008
Intensity of cervical inflammatory reaction as a risk factor for recurrence of carcinoma of the uterine cervix in stages IB and IIA
Abstract
Context and objective: Inflammatory reaction intensity has been indicated as a possible recurrence risk factor in carcinoma of the uterine cervix. Some authors observed greater risk with weak inflammatory reaction, while others described the opposite. This study aimed to evaluate risk factors for initial-stage uterine cervix carcinoma recurrence (IB and IIA), considering inflammatory reaction intensity.
Design and setting: Retrospective cohort at Hospital do Câncer A. C. Camargo.
Methods: 289 patients with diagnosed uterine cervix carcinoma (stages IB and IIA) who underwent radical surgery between 1980 and 1999 were studied. Data were collected from medical records. Histological sections from tumors and lymph nodes could be reviewed in 247 cases. Five-year disease-free survival rates were calculated using the Kaplan-Meier method and curves were compared using the log-rank test. Cox's proportional-hazards model was used for multivariate analysis. Recurrence risk was estimated using hazard ratios (HR).
Results: Forty-three recurrences were found. Multivariate analysis identified the following independent recurrence risk factors: number of metastatic pelvic lymph nodes (one lymph node: HR = 3.3 [1.3-8.3]; two or three: HR = 5.3 [1.5-18.6]; four or more: HR = 7.6 [1.7-33.2]), tumor invasion depth (deepest third: HR = 2.1 [1.1-4.1]) and inflammatory reaction intensity in the uterine cervix (absent or slight: HR = 2.5 [1.1-5.7]).
Conclusion: This study identified that absent or slight inflammatory reaction was an independent risk factor for recurrence. The other risk factors were the number of metastatic pelvic lymph nodes and invasion of the deepest third of the uterine cervix.
CONTEXTO E OBJETIVO:: A intensidade da reação inflamatória é citada como possível fator de risco para recorrência do carcinoma do colo do útero (CCU). Alguns autores observaram aumento do risco com reação inflamatória fraca, enquanto outros descreveram o oposto. Este estudo procurou avaliar os fatores de risco para recorrência do CCU em estádios iniciais (IB e IIA), considerando na análise a reação inflamatória.
TIPO DE ESTUDO E LOCAL:: Coorte retrospectiva, no Centro de Tratamento e Pesquisa Hospital A. C. Camargo (Hospital do Câncer).
MÉTODOS:: Estudaram-se 289 pacientes com diagnóstico de CCU (estádios IB e IIA) submetidas à cirurgia radical entre 1980 e 1999. Realizou-se a coleta de dados nos prontuários. Os cortes histológicos dos tumores e dos linfonodos foram revistos em 247 casos. As taxas de sobrevida livre de doença em cinco anos foram calculadas pelo método de Kaplan-Meier e as curvas comparadas pelo teste de log-rank. Para a análise multivariada empregou-se o modelo de riscos proporcionais de Cox. A estimativa do risco de recorrência foi o hazard ratio (HR).
RESULTADOS:: Registraram-se 43 recorrências. A análise multivariada identificou os seguintes fatores de risco independentes para recorrência: número de linfonodos pélvicos metastáticos (1 linfonodo: HR = 3,3 [1,3-8,3]; 2 ou 3 linfonodos: HR = 5,3 [1,5-18,6]; 4 ou mais linfonodos: HR=7,6 [1,7 – 33,2]), profundidade de invasão do tumor (terço profundo: HR = 2,1 [1,1-4,1]) e intensidade da reação inflamatória no colo do útero (ausente ou leve: HR = 2,5 [1,1-5,7]).
CONCLUSÃO:: Este estudo identificou a reação inflamatória ausente ou de intensidade leve como fatores de risco independentes para recorrência. Os outros fatores de risco foram o número de linfonodos pélvicos metastáticos e a invasão do terço profundo do colo do útero.
Conflict of interest statement
Similar articles
-
[Unusual risk factors for lymph node metastasis in cancer of the uterine cervix].Rev Assoc Med Bras (1992). 2007 Jul-Aug;53(4):338-43. doi: 10.1590/s0104-42302007000400020. Rev Assoc Med Bras (1992). 2007. PMID: 17823738 Portuguese.
-
Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.Eur J Obstet Gynecol Reprod Biol. 2008 Feb;136(2):215-23. doi: 10.1016/j.ejogrb.2006.10.021. Epub 2006 Nov 27. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 17125903
-
Menopausal status: a possible predictive factor for recurrence in women with cancer of the uterine cervix without pelvic lymph node metastasis.Eur J Obstet Gynecol Reprod Biol. 2009 Oct;146(2):204-9. doi: 10.1016/j.ejogrb.2009.04.006. Epub 2009 May 17. Eur J Obstet Gynecol Reprod Biol. 2009. PMID: 19450920
-
Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):645-51. doi: 10.1016/s0360-3016(99)00217-5. Int J Radiat Oncol Biol Phys. 1999. PMID: 10524418
-
Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.Cancer. 1997 Oct 1;80(7):1234-40. Cancer. 1997. PMID: 9317173
Cited by
-
Enzyme-labeled Antigen Method: Development and Application of the Novel Approach for Identifying Plasma Cells Locally Producing Disease-specific Antibodies in Inflammatory Lesions.Acta Histochem Cytochem. 2016 Feb 27;49(1):7-19. doi: 10.1267/ahc.15030. Epub 2016 Feb 26. Acta Histochem Cytochem. 2016. PMID: 27006517 Free PMC article. Review.
References
-
- Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(Suppl 8):S4–66. - PubMed
-
- Benedet JL, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2003;83(Suppl 1):41–78. - PubMed
-
- Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1974;44(2):265–272. - PubMed
-
- Wilkinson EJ, Malik S. National Institutes of Health Consensus Development Conference statement on cervical cancer. April 1-3, 1996. J Womens Health. 1998;7(5):604–605. - PubMed
-
- Chi DS, Gemignani ML, Curtin JP, Hoskins WJ. Long-term experience in the surgical management of cancer of the uterine cervix. Semin Surg Oncol. 1999;17(3):161–167. - PubMed